Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T19:33:56.250Z.
Calculation as of: 2026-10-06T19:33:56.250Z.
Quote observation: 2026-10-06T19:29:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$3.54M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| YYForce Inc. (YFOR) | $3.51M | N/A | N/A | N/A | N/A |
| Baiya International Group Inc. (BIYA)vs › | $3.54M | N/A | N/A | N/A | N/A |
| Addentax Group Corp. (ATXG)vs › | $3.34M | N/A | 0.48% | 0.37% | 0.37% |
| INLIF Limited (INLF)vs › | $3.64M | N/A | N/A | N/A | N/A |
| Polar Power, Inc. (POLA)vs › | $3.26M | N/A | 6.55% | 11.50% | 9.18% |
| Iveda Solutions, Inc. (IVDA)vs › | $3.17M | N/A | 0.66% | 0.66% | 0.66% |
| BioNexus Gene Lab Corp. (BGLC)vs › | $3.01M | N/A | 0.95% | 0.81% | 0.81% |
| Expion360 Inc. (XPON)vs › | $3.96M | N/A | N/A | N/A | N/A |
| PTL Limited (PTLE)vs › | $3.02M | N/A | N/A | N/A | N/A |
| E-Power Inc. Class A (EPOW)vs › | $3.82M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute